Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × copanlisib × 90 days × Clear all

Sponsor

Conditions

Lymphoma 3 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Endometrial Neoplasms 2 Triple Negative Breast Neoplasms 1 Malignant Solid Neoplasm 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Fallopian Tube Neoplasms 1 Disease Progression 1

Interventions

Biopsy 5 Specimen Handling 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 belinostat 2 X-Rays 2 Whole-Body Irradiation 2 10-propargyl-10-deazaaminopterin 2 tazemetostat 1 talimogene laherparepvec 1 sodium-iodide symporter 1 ruxolitinib 1 romidepsin 1 fludarabine 1 enasidenib 1 duvelisib 1 cemiplimab 1 brincidofovir 1 Triamcinolone 1 Tacrolimus 1 Spinal Puncture 1 Solutions 1 Rituximab 1 Photons 1 Pharmacokinetics 1 Pharmacogenomic Variants 1 Peripheral Blood Stem Cell Transplantation 1 Nivolumab 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mycophenolic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡